| 翻訳と辞書 |
| La Trobe Institute for Molecular Science ： ウィキペディア英語版 |
La Trobe Institute for Molecular Science
The La Trobe Institute for Molecular Science (LIMS) is an Australian research institute based at La Trobe University in Melbourne. It contains research groups in life sciences (biochemistry and genetics), physical sciences (chemistry and physics), and applied sciences (pharmacy) and teaches undergraduate and graduate courses in these areas through the School of Molecular Sciences. It also contains two biotech companies: Hexima and AdAlta. The institute is housed in three buildings: LIMS1 and LIMS2 on La Trobe University’s main campus in Bundoora, and the Applied Science building on the Bendigo campus.
== History ==
LIMS was launched in 2009 as an institute dedicated to the study of molecular structures and processes fundamental to life. The institute was established with a A$100 million in building funds from the Australian Government and La Trobe University. In 2015 the institute released its new stated vision to conduct multidisciplinary research in six key areas of research strength: cancer, infection and immunity, neurobiology, molecular design, molecular imaging and molecular sensing. Professor Nick Hoogenraad served as the institute's Director from its founding in 2009 until his retirement in 2014, when the LIMS1 Auditorium was named after him. Professor Robert Pike joined La Trobe as Director of LIMS in 2015.
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「La Trobe Institute for Molecular Science」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|